| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |